Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20210315906Botanical Extracts and Compounds from Schinus Plants and Methods of Use
US 14.10.2021
Int.Class A61K 31/569
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
565not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
568substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
569substituted in position 17 alpha, e.g. ethisterone
Appl.No 17357353 Applicant Emory University Inventor Cassandra L. Quave

This disclosure relates to extracts from the Anacardiaceae (cashew plant family) and compositions comprising compounds contained therein. In certain embodiments, the extracts are derived from the fruit of a Schinus plant. In certain embodiments, the disclosure relates to methods of treating or preventing bacterial infections, acne, and other related uses.

2.WO/2021/203648TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING GINGIVAL ATROPHY AND/OR TREATING GINGIVITIS
WO 14.10.2021
Int.Class A61K 36/899
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Appl.No PCT/CN2020/120107 Applicant SICHUAN GREEN HERB TECHNOLOGY DEVELOPMENT CO., LTD Inventor ZHOU, Houcheng
Disclosed is a traditional Chinese medicine composition for preventing gingival atrophy and/or treating gingivitis. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 5-7 parts of rhizoma chuanxiong, 6-9 parts of rhizoma imperatae, 4-6 parts of and herba agrimoniae, and 2-4 parts of radix astragali. The traditional Chinese medicine composition has precise compatibility and a synergistic effect, can prevent redness and swelling and bleeding of the gum, gingival atrophy and other symptoms, and can effectively treat gingivitis. The composition can be applied to preparation of toothpaste, mouth wash and other oral products, and has a good market prospect.
3.WO/2021/203933TRADITIONAL CHINESE MEDICINE FOR DISPERSING LUNG QI AND DETOXICATION
WO 14.10.2021
Int.Class A61K 36/8994
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
8994Coix (Job's tears)
Appl.No PCT/CN2021/081339 Applicant SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Inventor ZHANG, Boli
A traditional Chinese medicine for dispersing lung qi and detoxication, a preparation method therefor, use thereof, and an analysis method. This traditional Chinese medicine contains a traditional Chinese medicine active extract. The active extract is composed of a first extract and a second extract, wherein the first extract is a water extract or alcohol-water extract of ephedra, bitter apricot seed, raw gypsum, coix seed, rhizome of swordlike atractylodes, patchouli, polygonum cuspidatum, verbena, reed rhizome, lepidium seed, pummelo peel, and artemisia annua, the second extract is a water extract or an alcohol-water extract of licorice, and the first extract and the second extract are separately obtained. This traditional Chinese medicine can be used for treating coronavirus diseases, such as novel coronavirus pneumonia.
4.102021001609Verfahren zur Herstellung einer Substanz
DE 14.10.2021
Int.Class A23L 27/00
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
27Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
Appl.No 102021001609 Applicant Ziesmer Friederike Inventor gleich Anmelder

Die vorliegenden Erfindung betrifft ein Verfahren zur Herstellung einer Substanz, wobei das Verfahren als Zutaten Wasser, Feigen oder Datteln, Knoblauch, Salbei, Koriandersamen, Wachholderbeeren, Thymian, RMS-Tropfen, sowie Galgant oder Ingwer in einem Mischungsverhältnis zusammenfügt, um die Substanz herzustellen.

5.20210315809ORAL CARE COMPOSITIONS AND METHODS
US 14.10.2021
Int.Class A61K 9/68
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
68chewing gum type
Appl.No 17227978 Applicant Per Os Biosciences, LLC Inventor Robert Estey

Oral formulations include a polysaccharide, such as, chitosan and an anthocyanin-rich extract from dark berries. These oral formulations are manufactured in various permutations such as a chewing gum or lozenge which incorporate chitosan and berry extract powder for protecting the oral cavity from the bacteria that cause gingivitis and periodontitis.

6.20210315955COMPOSITIONS AND METHODS FOR TREATMENT OF RESPIRATORY AILMENTS
US 14.10.2021
Int.Class A61K 36/428
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
42Cucurbitaceae (Cucumber family)
428Trichosanthes
Appl.No 17226361 Applicant Bert Forman Inventor Bert Forman

Compositions and methods for treating respiratory ailments are disclosed.

7.20210315802FILM DOSAGE FORM WITH EXTENDED RELEASE MUCOADHESIVE PARTICLES
US 14.10.2021
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No 17346874 Applicant Intelgenx Corp. Inventor Rodolphe Obeid

An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.

8.WO/2021/206724FERMENTED ONION COMPOSITION
WO 14.10.2021
Int.Class A23L 2/38
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
2Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
38Other non-alcoholic beverages
Appl.No PCT/US2020/027569 Applicant PURAC BIOCHEM B.V. Inventor CHAREST, David, John
The invention relates to a fermented onion composition having a dry matter content of at least 8 wt.%, said composition comprising, per gram of dry matter: a) 0-150 mg of saccharides selected from fructose, glucose, sucrose and combinations thereof; b) 5-250 mg of phenols selected from acid equivalent of gallic acid, acid equivalent of ferulic acid, quercetin, kaempferol and combinations thereof; c) 75-500 mg acid equivalent of organic acid selected from propionic acid, lactic acid, acetic acid and combinations thereof. The fermented onion composition of the present invention can advantageously be used as an effective, label-friendly food ingredient to increase overall quality of foods. The invention also provides a method of preparing a fermented onion composition, comprising: • providing an onion substrate containing 10-50 wt.% dry matter and 50-90 wt.% water, wherein at least 40 wt.% of the dry matter is derived from onion; • inoculating the substrate with a micro-organism selected from lactic acid bacteria, Propionibacterium and combinations thereof; and • incubating the inoculated substrate at a temperature in the range of 25-60°C for at least 12 hours to produce an onion ferment.
9.20210315812Structured Rheological Solid Personal Care Composition
US 14.10.2021
Int.Class A61K 9/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
06Ointments; Bases therefor
Appl.No 17225218 Applicant The Procter & Gamble Company Inventor Matthew Lawrence Lynch

A rheological solid personal care composition comprises a crystallizing agent, a suspension agent, an insoluble active, and an aqueous phase. A process for the manufacture of a rheological solid composition comprises the steps of: provision and heat up of an aqueous solution of sodium chloride, and sodium hydroxide; addition of an emulsifier, preferably palmitic acid, in order to obtain an emulsifier main mix, preferably a sodium palmitate soap main mix; addition of a suspension agent, preferably xanthan gum and glycerin, to the emulsifier main mix; addition of an insoluble active premix to the emulsifier main mix to obtain a blend, the insoluble active premix preferably being a petrolatum-based premix of topical drug actives, the topical drug active preferably selected from the group of: menthol, nutmeg, camphor, eucalyptus, cedar leaf, thymol, and any combinations thereof; cool down of the blend in order to form a crystalline structure of the rheological solid composition; optionally, addition of a hygroscopic stabilizer to the blend in order to stabilize the crystalline structure, the hygroscopic stabilizer preferably being sodium lactate.

10.20210315227STABILIZED COMPOSITIONS CONTAINING EDIBLE OIL AND THEIR USES IN FOOD PRODUCTS
US 14.10.2021
Int.Class A23D 9/06
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
9Other edible oils or fats, e.g. shortenings, cooking oils
06Preservation of finished products
Appl.No 17271733 Applicant ROQUETTE FRERES Inventor Bernard PORA

The present invention relates to a composition comprising:

    • (i) from 10 to 40% by weight, preferably from 20 to 30% by weight of an edible oil;
    • (ii) lactose and
    • (iii) mannitol

wherein the edible oil comprises at least 20% by weight, preferably between 25 and 40% by weight, typically 30 and 35% by weight of polyunsaturated fatty acids and the weight ratio of lactose to mannitol is from 1:3 to 3:1, preferably between 1:2 to 2:1, more preferably 1:1.